Ananda Developments Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions. It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities. The company was formerly known as Longdog Investments Plc and changed its name to Ananda Developments Plc in May 2018. Ananda Developments Plc was incorporated in 2018 and is based in London, the United Kingdom.
Metrics to compare | ANAA | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipANAAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.4x | −2.0x | −0.6x | |
PEG Ratio | 0.15 | −0.01 | 0.00 | |
Price/Book | −17.9x | 2.1x | 2.6x | |
Price / LTM Sales | 20,137.3x | 3.2x | 3.2x | |
Upside (Analyst Target) | - | 101.6% | 49.4% | |
Fair Value Upside | Unlock | 14.0% | 7.8% | Unlock |